Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetroGel 1% Hydration Study
NCT00436527Phase 4Completed
- Sponsor
- Galderma
- Start
- Aug 2006
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of MetroGel 1% in rosacea, sponsored by Galderma. Primary endpoint: Corneometer CM 825 measurements at 8 hours. Started Aug 2006; status: completed.
02
Drugs
MetroGel 1%
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT00436527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436527.